Biological Psychiatry
Volume 67, Issue 2 , Pages 101-109 , 15 January 2010

Bilateral Epidural Prefrontal Cortical Stimulation for Treatment-Resistant Depression

Portions of this work were presented at the Annual Meeting of the American College of Neuropsychopharmacology, Scottsdale, Arizona, in December 2008.

  • Ziad Nahas

      Affiliations

    • Department of Psychiatry, Mood Disorders Program and Brain Stimulation Laboratory, Medical University of South Carolina, Charleston, South Carolina
    • Department of Neuroscience, Medical University of South Carolina, Charleston, South Carolina
    • Corresponding Author InformationAddress correspondence to Ziad Nahas, M.D., M.S.C.R., Institute of Psychiatry, 67 President Street, Charleston, SC 29425
    • ,
  • Berry S. Anderson

      Affiliations

    • Department of Psychiatry, Mood Disorders Program and Brain Stimulation Laboratory, Medical University of South Carolina, Charleston, South Carolina
    • ,
  • Jeff Borckardt

      Affiliations

    • Department of Psychiatry, Mood Disorders Program and Brain Stimulation Laboratory, Medical University of South Carolina, Charleston, South Carolina
    • Department of Anesthesia and Perioperative Medicine, Medical University of South Carolina, Charleston, South Carolina
    • ,
  • Ashley B. Arana

      Affiliations

    • Department of Psychiatry, Mood Disorders Program and Brain Stimulation Laboratory, Medical University of South Carolina, Charleston, South Carolina
    • ,
  • Mark S. George

      Affiliations

    • Department of Psychiatry, Mood Disorders Program and Brain Stimulation Laboratory, Medical University of South Carolina, Charleston, South Carolina
    • Department of Neuroscience, Medical University of South Carolina, Charleston, South Carolina
    • Department of Radiology, Medical University of South Carolina, Charleston, South Carolina
    • Ralph H. Johnson VA Medical Center, Charleston, South Carolina
    • ,
  • Scott T. Reeves

      Affiliations

    • Department of Anesthesia and Perioperative Medicine, Medical University of South Carolina, Charleston, South Carolina
    • ,
  • Istvan Takacs

      Affiliations

    • Department of Neuroscience, Medical University of South Carolina, Charleston, South Carolina
    • Department of Neurosurgery, Medical University of South Carolina, Charleston, South Carolina

Received 12 June 2009 ,Revised 5 August 2009 ,Accepted 11 August 2009.

References 

  1. Murray CJ, Lopez AD. Global mortality, disability, and the contribution of risk factors: Global burden of disease study. Lancet. 1997;349:1436–1442
  2. Greden JF. The burden of recurrent depression: Causes, consequences, and future prospects. J Clin Psychiatry. 2001;62(suppl 22):5–9
  3. Greenberg PE, Kessler RC, Birnbaum HG, Leong SA, Lowe SW, Berglund PA, et al. The economic burden of depression in the United States: How did it change between 1990 and 2000?. J Clin Psychiatry. 2003;64:1465–1475
  4. Berto P, D'Ilario D, Ruffo P, Di Virgilio R, Rizzo F. Depression: Cost-of-illness studies in the international literature, a review. J Ment Health Policy Econ. 2000;3:3–10
  5. Kessler RC, Berglund P, Demler O, Jin R, Koretz D, Merikangas KR, et al. The epidemiology of major depressive disorder: Results from the national comorbidity survey replication (NCS-R). J Am Med Assoc. 2003;289:3095–3105
  6. Klerman GL, Weissman MM. Increasing rates of depression. J Am Med Assoc. 1989;261:2229–2235
  7. Robins LN, Regier DA. Psychiatric Disorders in America: The Epidemiological Catchment Area Study. New York: Free Press; 1991;
  8. Rush AJ, Trivedi MH, Wisniewski SR, Nierenberg AA, Stewart JW, Warden D, et al. Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: A STAR*D report. Am J Psychiatry. 2006;163:1905–1917
  9. Nahas Z, Lorberbaum JP, Kozel FA, George MS. Somatic treatment in psychiatry. In:  Panksepp J editors. Textbook of Biological Psychiatry. Hoboken, NJ: John Wiley & Sons; 2003;p. 521–548
  10. Davidson RJ, Pizzagalli D, Nitschke JB, Putnam K. Depression: Perspectives from affective neuroscience. Annu Rev Psychol. 2002;53:545–574
  11. Raichle ME, Snyder AZ. A default mode of brain function: A brief history of an evolving idea. Neuroimage. 2007;37:1083–1089
  12. Goldman-Rakic PS. Topography of cognition: Parallel distributed networks in Primate Association Cortex. Annu Rev Neurosci. 1988;11:137–156
  13. Petrides M, Pandya D. Efferent association pathways from the rostral prefrontal cortex in the macaque monkey. J Neurosci. 2007;27:11573–11586
  14. Ramnani N, Owen A. Anterior prefrontal cortex: Insights into function from anatomy and neuroimaging. Nat Rev Neurosci. 2004;5:184–194
  15. Posner MI, et al. Localization of cognitive operations in the human brain. Science. 1988;240:1627–1631
  16. Kjaer TW, et al. Increased dopamine tone during meditation-induced change of consciousness. Brain Res Cogn Brain Res. 2002;13:255–259
  17. Vogeley K, Bussfeld P, Newen A, Herrmann S, Happé F, Falkai P, et al. Mind reading: Neural mechanisms of theory of mind and self-perspective. Neuroimage. 2001;14:170–181
  18. Petrides M. Lateral prefrontal cortex: Architectonic and functional organization. Philos Trans R Soc Lond B Biol Sci. 2005;360:781–795
  19. Priori A, Lefaucheur JP. Chronic epidural motor cortical stimulation for movement disorders. Lancet Neurol. 2007;6:279–286
  20. Nahas Z, et al. Safety and benefits of distance-adjusted prefrontal transcranial magnetic stimulation in depressed patients 55–75 years of age: a pilot study. Depress Anxiety. 2004;19:249–256
  21. Nahas Z, et al. Unilateral left prefrontal transcranial magnetic stimulation (TMS) produces intensity-dependent bilateral effects as measured by interleaved BOLD fMRI. Biol Psychiatry. 2001;50:712–720
  22. Nahas Z, Li X, Kozel FA, Mirzki D, Memon M, Miller K, et al. Two-year outcome of vagus nerve stimulation (VNS) for treatment of major depressive episodes. J Clin Psychiatry. 2005;66:1097–1104
  23. Nahas Z, Teneback C, Chae JH, Mu Q, Molnar C, Kozel FA, et al. Serial vagus nerve stimulation functional MRI in treatment-resistant depression. Neuropsychopharmacology. 2007;32:1649–1660
  24. Canavero S, Bonicalzi V. Therapeutic extradural cortical stimulation for central and neuropathic pain: A review. Clin J Pain. 2002;18:48–55
  25. Schlaepfer TE, Cohen MX, Frick C, Kosel M, Brodesser D, Axmacher N, et al. Deep brain stimulation to reward circuitry alleviates anhedonia in refractory major depression. Neuropsychopharmacology. 2008;33:368–377
  26. Mayberg HS, Lozano AM, Voon V, McNeely HE, Seminowicz D, Hamani C, et al. Deep brain stimulation for treatment-resistant depression. Neuron. 2005;45:651–660
  27. Nguyen JP, Lefaucher JP, Le Guerinel C, Eizenbaum JF, Nakano N, Carpentier A, et al. Motor cortex stimulation in the treatment of central and neuropathic pain. Arch Med Res. 2000;31:263–265
  28. Nguyen JP, Keravel Y, Feve A, Uchiyama T, Cesaro P, Le Guerinel C, et al. Treatment of deafferentation pain by chronic stimulation of the motor cortex: Report of a series of 20 cases. Acta Neurochir Suppl. 1997;68:54–60
  29. Tsubokawa T, Katayama Y, Yamamoto T, Hirayama T, Koyama S. Chronic motor cortex stimulation for the treatment of central pain. Acta Neurochir Suppl. 1991;52:137–139
  30. Brown JA, Lutsep HL, Weinand M, Cramer SC. Motor cortex stimulation for the enhancement of recovery from stroke: A prospective, multicenter safety study. Neurosurgery. 2006;58:464–473
  31. Dougherty DD, Thase ME, Howland RH, Evans KC, Harsch H, Kondziolka D, et al. Feasibility study of an implantable cortical stimulation system for patients with major depressive disorder. 2008;Presented at the Society of Biological Psychiatry 63rd Annual Meeting, Washington, D.C.
  32. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders: DSM-IV. 4th ed.. Washington, DC: American Psychiatric Press; 1994;
  33. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry. 1960;12:56–62
  34. Williams JB. A structured interview guide for the Hamilton Depression Rating Scale. Arch Gen Psychiatry. 1988;45:742–747
  35. Sackeim HA. The definition and meaning of treatment-resistant depression. J Clin Psychiatry. 2001;62(suppl 16):10–17
  36. Nyhuis PW, Gastpar M, Scherbaum N. Opiate treatment in depression refractory to antidepressants and electroconvulsive therapy. J Clin Psychopharmacol. 2008;28:593–595
  37. Berman RM, Cappiello A, Anand A, Oren DA, Heninger GR, Charney DS, et al. Antidepressant effects of ketamine in depressed patients. Biol Psychiatry. 2000;47:351–354
  38. Frye MA, Ketter TA, Altshuler LL, Denicoff K, Dunn RT, Kimbrell TA, et al. Clozapine in bipolar disorder: Treatment implications for other atypical antipsychotics. J Affect Disord. 1998;48:91–104
  39. Belanoff JK, Flores BH, Kalezhan M, Sund B, Schatzberg AF. Rapid reversal of psychotic depression using mifepristone. J Clin Psychopharmacol. 2001;21:516–521
  40. Endicott J, Nee J, Harrison W, Blumenthal R. Quality of Life Enjoyment and Satisfaction Questionnaire: a new measure. Psychopharmacol Bull. 1993;29:321–326
  41. Ware JE, Sherbourne CD. The MOS 36-item short-form health survey (SF-36) (I. Conceptual framework and item selection). Med Care. 1992;30:473–483
  42. Valentini LG, Casali C, Chatenoud L, Chiaffarino F, Uberti-Foppa C, Broggi G. Surgical site infections after elective neurosurgery: A survey of 1747 patients. Neurosurgery. 2008;62:88–95discussion: 95–96
  43. Lozano AM, Mayberg HS, Giacobbe P, Hamani C, Craddock RC, Kennedy SH. Subcallosal cingulate gyrus deep brain stimulation for treatment-resistant depression. Biol Psychiatry. 2008;64:461–467
  44. Anisman H, Merali Z. Cytokines, stress, and depressive illness. Brain Behav Immun. 2002;16:513–524
  45. Vedder H, Schreiber W, Schuld A, Kainz M, Lauer CJ, Krieg JC, et al. Immune-endocrine host response to endotoxin in major depression. J Psychiatr Res. 2007;41:280–289
  46. Marangell LB, Rush AJ, George MS, Sackeim HA, Johnson CR, Husain MM, et al. Vagus nerve stimulation (VNS) for major depressive episodes: One year outcomes. Biol Psychiatry. 2002;51:280–287
  47. Rush AJ, Marangell LB, Sackeim HA, George MS, Brannan SK, Davis SM, et al Vagus nerve stimulation for treatment-resistant depression: A randomized, controlled acute phase trial. Biol Psychiatry. 2005;58:347–354
  48. Rush AJ, Sackeim HA, Marangell LB, George MS, Brannan SK, Davis SM, et al. Effects of 12 months of vagus nerve stimulation in treatment-resistant depression: A naturalistic study. Biol Psychiatry. 2005;58:355–363
  49. Sackeim HA, Brannan SK, Rush AJ, George MS, Marangell LB, Allen J. Durability of antidepressant response to vagus nerve stimulation (VNSTM). Int J Neuropsychopharmacol. 2007;10:817–826
  50. Nahas Z, Marangell LB, Husain MM, Rush AJ, Sackeim HA, Lisanby SH, et al. Two-year outcome of vagus nerve stimulation (VNS) for treatment of major depressive episodes. J Clin Psychiatry. 2005;66:1097–1104
  51. George M. A one-year comparison of vagus nerve stimulation with treatment as usual for treatment-resistant depression. Biol Psychiatry. 2005;58:364–373
  52. Rush AJ, George MS, Sackeim HA, Marangell LB, Husain MM, Giller C, et al. Vagus nerve stimulation (VNS) for treatment-resistant depressions: A multicenter study. Biol Psychiatry. 2000;47:276–286
  53. Nierenberg AA, Alpert JE, Gardner-Schuster EE, Seay S, Mischoulon D. Vagus nerve stimulation: 2-year outcomes for bipolar versus unipolar treatment-resistant depression. Biol Psychiatry. 2008;64:455–460
  54. Pool JL. Psychosurgery of older people. J Geriatr Assoc. 1954;2:456–465
  55. Mark VH, Barry H, McLardy T, Ervin FR. The destruction of both anterior thalamic nuclei in a patient with intractable agitated depression. J Nerv Ment Dis. 1970;150:266–272
  56. Greenberg BD. Update on deep brain stimulation. J ECT. 2002;18:193–196
  57. García-Larrea L, Peyron R, Mertens P, Laurent B, Mauguière F, Sindou M. Functional imaging and neurophysiological assessment of spinal and brain therapeutic modulation in humans. Arch Med Res. 2000;31:248–257
  58. Nahas Z, Teneback CC, Kozel A, Speer AM, DeBrux C, Molloy M, et al. Brain effects of TMS delivered over prefrontal cortex in depressed adults: Role of stimulation frequency and coil-cortex distance. J Neuropsychiatr Clin Neurosci. 2001;13:459–470
  59. Li X, Nahas Z, Kozel FA, Anderson B, Bohning DE, George MS. Acute left prefrontal transcranial magnetic stimulation in depressed patients is associated with immediately increased activity in prefrontal cortical as well as subcortical regions. Biol Psychiatry. 2004;55:882–890
  60. Kose S, Lix , Morgan PS, Anderson B, Nahas Z, George MS, et al. Does the effect of prefrontal rTMS on corticolimbic circuits vary as A function of mood state? (Interleaved TMS-fMRI scans in treatment resistant depression patients in the NIMH OPT-TMS study). 2008;Presented at the Annual Meeting of the American College of Neuropsychopharmacology, Scottsdale, AZ.
  61. Nahas Z, Teneback C, Chae JH, Mu Q, Molnar C, Kozel FA, et al. Serial vagus nerve stimulation functional MRI in treatment-resistant depression. Neuropsychopharmacology. 2007;32:1649–1660
  62. Vitek JL. Mechanisms of deep brain stimulation: Excitation or inhibition. Mov Disord. 2002;17(suppl 3):S69–S72
  63. Hajcak G, Takacs S, Anderson B, Borckardt J, Reeves S, Arana A, et al.: Direct bilateral epidural prefrontal cortical electrical stimulation (EpCS) down-regulates amygdala-mediated emotional appraisal in treatment-resistant depression. Poster presentation at the American College of Neuropsychopharmacology, Scottsdale, AZ.

PII: S0006-3223(09)01020-8

doi: 10.1016/j.biopsych.2009.08.021

Biological Psychiatry
Volume 67, Issue 2 , Pages 101-109 , 15 January 2010

Article Tools

* Image Usage & Resolution